Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $29.3 million.

  • PROCEPT BioRobotics' Cost of Revenue rose 3663.73% to $29.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.3 million, marking a year-over-year increase of 2484.82%. This contributed to the annual value of $87.4 million for FY2024, which is 3416.69% up from last year.
  • Latest data reveals that PROCEPT BioRobotics reported Cost of Revenue of $29.3 million as of Q3 2025, which was up 3663.73% from $27.4 million recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' Cost of Revenue registered a high of $29.3 million during Q3 2025, and its lowest value of $3.7 million during Q1 2021.
  • Its 5-year average for Cost of Revenue is $15.3 million, with a median of $14.7 million in 2023.
  • In the last 5 years, PROCEPT BioRobotics' Cost of Revenue surged by 13303.09% in 2022 and then surged by 1002.42% in 2024.
  • PROCEPT BioRobotics' Cost of Revenue (Quarter) stood at $5.6 million in 2021, then surged by 133.03% to $13.1 million in 2022, then soared by 70.41% to $22.3 million in 2023, then increased by 10.02% to $24.6 million in 2024, then grew by 19.37% to $29.3 million in 2025.
  • Its Cost of Revenue was $29.3 million in Q3 2025, compared to $27.4 million in Q2 2025 and $25.0 million in Q1 2025.